Spero-Smith Investment Advisers’s Pfizer PFE Stock Holding History

Spero-Smith Investment Advisers’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$220K	Buy	+6,852	New	+$229K	0.3%	49

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Spero-Smith Investment Advisers's PFE Position: Q3 2016 in Review

Spero-Smith Investment Advisers opened a new position in Pfizer (PFE) in Q3 2016: 6,852 shares worth $220K. The stake represents 0.3% of the portfolio and ranks #49 among its holdings.

1,963 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

Spero-Smith Investment Advisers held 6,852 shares of Pfizer worth $220K as of Q3 2016.
Pfizer was a new Spero-Smith Investment Advisers position in Q3 2016.
Pfizer made up 0.3% of Spero-Smith Investment Advisers's portfolio in Q3 2016, its #49 holding.
1,963 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on Spero-Smith Investment Advisers's 13F filing for Q3 2016, filed 31 Oct 2016.